RxDoctor Payments Data

Jeffrey Fogt, OD

Optometrist · Defiance, OHNPI 1427041342

Payments from drug & device makers

What this record shows

The money is spread across several categories — travel and lodging (43.3%), food and beverage and speaking fees — rather than concentrated in one kind of arrangement. 7 manufacturers reported payments, led by Alcon at 52.1% of the total. Reporting peaked in 2021 at $2,007 and has fallen 96.2% since, to $77 in 2025. Among optometrist clinicians in OH with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$4,985in general payments, 2019–2025

Across 47 payments — averaging $106.06 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Alcon$3K
  • Bausch & Lomb, A Division Of Bausch Health US, LLC$2K
  • Bausch & Lomb Americas Inc.$304
  • Lombart Brothers, Inc.$126
  • AbbVie$108
  • Biotissue Holdings Inc.$56
  • plus $40 from 1 others

What the payments were for

  • Speaking & faculty fees$1,05021%
  • Travel & lodging$2,15943%
  • Food & beverage$1,77636%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,985 in reported general payments places this provider in the 90th percentile of 1,995 optometrist providers in Ohio.

See all optometrist providers in Ohio →

Medicare billing

Part B allowed, 2024
$14,477
Medicare patients
118
Services billed
138

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Latanoprost46$114

Paid to pharmacies, not to this prescriber.

Other optometrist in Defiance

See the full list for Ohio →

Where these figures come from

Is this you, or does something look wrong? →